KIR2DL2/C1 is a Risk Factor for Chronic Infection and Associated with Non-response to PEG-IFN and RBV Combination Therapy in Hepatitis C Virus Genotype 1b Patients in China.
Ontology highlight
SUBMITTER: Hu S
PROVIDER: S-EPMC6178104 | biostudies-literature | 2018 Aug
REPOSITORIES: biostudies-literature
ACCESS DATA